Atomwise
Atomwise's Overview
Atomwise is a leading artificial intelligence (AI) drug discovery company, pioneering the use of deep learning for the design and development of novel small molecule therapies. Their patented AtomNet® technology employs convolutional neural networks to analyze vast datasets, predicting how molecules will bind to target proteins with unprecedented speed and accuracy. This approach aims to significantly reduce the time and cost of R&D, tackle previously 'undruggable' targets, and accelerate the journey of new medicines to patients. Atomwise collaborates with pharmaceutical companies, biotech firms, and academic institutions worldwide to advance a diverse pipeline of therapeutic programs across various disease areas.
Where is Atomwise's Headquarters?
HQ Function
Serves as the primary center for Atomwise's research and development, business operations, engineering, data science, and corporate leadership.
Notable Features:
Located in a modern office building in downtown San Francisco, offering accessibility and proximity to other tech companies, research institutions, and venture capital firms. The office space is designed to foster collaboration and innovation.
Work Culture:
Atomwise fosters a mission-driven, collaborative, and innovative work culture. Employees are passionate about leveraging AI to solve complex biological problems and improve human health. The environment encourages learning, intellectual curiosity, and cross-functional teamwork.
HQ Significance:
The San Francisco Bay Area location provides access to a rich talent pool in AI, software engineering, and biotechnology, crucial for Atomwise's cutting-edge work. It also facilitates partnerships and networking within the vibrant life sciences ecosystem.
Values Reflected in HQ: The headquarters' location and design reflect Atomwise's commitment to innovation, technological advancement, collaboration, and attracting top talent to pursue its mission of transforming drug discovery.
Location:
While Atomwise's primary operations are based in its San Francisco headquarters, its collaborations and partnerships span globally. The company works with pharmaceutical companies, research institutions, and biotech firms across North America, Europe, and Asia to advance drug discovery programs. Their AI platform supports drug discovery efforts for diseases affecting populations worldwide, giving them a significant international impact through their technology and partnerships.
Street Address:
717 Market Street, Suite 800
City:
San Francisco
State/Province:
CA
Country:
USA
Atomwise's Global Presence
Buying Intent Signals for Atomwise
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Atomwise
As of April 2025, Atomwise' leadership includes:
Investors of Atomwise
Atomwise has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past year, Atomwise has seen some strategic leadership transitions. Notably, Karen Akinsanya moved from an executive role to a strategic advisor. No major C-suite hires have been publicly announced recently, indicating stability in the core leadership team.
Departures
Technology (Tech Stack) used by Atomwise
Discover the tools Atomwise uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Atomwise Email Formats and Examples
Atomwise likely utilizes common corporate email formats. The most probable patterns are first initial followed by last name, or first name followed by a period then last name, at their domain atomwise.com.
Common formats include: [first_initial][last]@atomwise.com (e.g., jdoe@atomwise.com) or [first].[last]@atomwise.com (e.g., jane.doe@atomwise.com).
Format
aheifets@atomwise.com
Example
80%
Success rate
News and media
PR Newswire • March 7, 2024
Atomwise and Klick Applied Sciences Partner to Accelerate Discovery of Novel Parkinson's Disease Therapeutics
Atomwise announced a collaboration with Klick Applied Sciences to discover novel small molecule therapies for Parkinson's disease, leveraging Atomwise's AI platform and Klick's expertise in biological and health data....more
Business Wire • February 13, 2024
Atomwise Unveils AI Model to Predict Peptide Binding to MHC Class I Molecules for Advancing Immunotherapies
Atomwise introduced an advanced AI model capable of predicting peptide binding to Major Histocompatibility Complex (MHC) Class I molecules, aiming to accelerate the development of personalized cancer vaccines and immunotherapies....more
Atomwise Press Release • October 26, 2023
Atomwise Announces Multi-Target Collaboration with Sanofi to Discover Novel Small Molecule Drug Candidates
Atomwise and Sanofi entered a multi-year research collaboration to use Atomwise's AI platform for discovering small molecule drug candidates against up to five drug targets. Atomwise received an upfront payment and is eligible for milestone payments and royalties....more
PR Newswire • November 2, 2022
Atomwise Announces Drug Discovery Collaboration with Warner Babcock Institute, Initially Focused on 'Undruggable' Targets in Oncology
Atomwise announced a collaboration with the Warner Babcock Institute for Green Chemistry (WBI) to identify and develop small molecule compounds for challenging oncology targets, combining Atomwise's AI platform with WBI's expertise in green chemistry and molecular design....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Atomwise, are just a search away.